InvestorsHub Logo
Followers 31
Posts 2308
Boards Moderated 0
Alias Born 02/12/2002

Re: None

Tuesday, 03/27/2012 5:05:48 PM

Tuesday, March 27, 2012 5:05:48 PM

Post# of 5675
Every move that CTDH makes is well thought out and moving the company forward. The agreement with UNO Healthcare is just another example. Look at CTDH's annual report: 86% of the revenue was from Trappsol products $889,000. Only around 15 to 20 people world wide are getting treated for Niemann Pick C currently. The world wide estimates of people with NPC are between 500 to 5,000. If CTHD can treat 150 that would mean revenue upwards of 10 times current levels. Agreements like that with UNO Healthcare will rapidly expand the number of people being treated and will also open up doors for selling other CTDH products.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYTH News